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The n e utrophil-activating peptide 1/interleukin 8 (NAP-1 1 
IL-8) h as in the past been extensively characterized biochem-
ically as wel l as functionally. Effects of NAP-1 / IL- 8 on in-
flammatory cells like neutrophilic g ranulocytes and 
lymphocytes, as well as it~ production by ~everal differ~ l~t cell 
types, point towards an Important role 111 different Inflam-
matory processes. R ecently, monoclonal antibodies have 
helped to estab!ish ~mmunoassays for detec~in~ the peptide. 
Using such antibodies, we h ave performed In Illtro studies on 
the time- and stimulus-dependent production of IL-8 by en-
dothelial cell s as well as fibroblasts. Tumor necrosis factor-a 
(TNF-a) and interleukin-la (IL-la) efficientl y induced 
I n 1986 a novel peptide now generall y referred to as neutro-phil-activating peptide l/interleukin 8 (NAP-1/IL-8) -:as detected and described by virtue of its near-selective actlVlty on human neutrop hilic gra nulocytes [1 - 3). Originally it was noted to be present in scale material from patients with psori-
asis [4). * Eventually it was purified from supernatants of stImulated 
human mononuclear cell s [1 ,2,3,5)' but in the meantime, apart from 
monocytes, fibroblasts [6,7) , endothelial cells [8,9), and kerat1l10-
cytes (7)1" were shown to be producers.of this cy~okine: Altl~ough 
lymphocyte chemotactic [10) and keratll10cyte mlto.gemc actlVl ty~: 
have been detected as well , activation of neutrophIlIc granulocytes 
remains the most prominent feature. This comprises degranulation 
w ith release of myeloperoxidase, p-glucuronidase, and elastase 
[1,2,4,5), generation of toxic oxygen radicals [1 ,2,3,5), as we ll as 
chemotaxis [1 ,5). 
In these studies a number of functional assays have been estab-
lished in conjunction with biochemical techniques in order to detect 
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both focal intracellular express ion as well as secretion of the 
peptide when tested by immunocytochemistry and enzyme-
linked inuTIunosorbent assay (ELISA). After stimulation with 
phorbol myristate acetate (PMA) and lipopolysaccharide 
(LPS) , such effects were seen only in endothelial cells, 
whereas interferon (I FN)-y did not induce any pronounced 
effect on either of the cells tested. These studies demon-
st~ated i,? "itro release of IL-8 by different cells upon specific 
stllTIulatlOn, thus underlining the significance of the in vivo 
secretion of this peptide, as noted in recent studies. Key 
words: IL-8 -ELISA/IL-8 - immunocytochemistry I ill lIitro 
stimulation. ] Invest Dermatoll 01 :573-576, 1993 
~ither of these activi ties [1 - 5). Often such assays are time-consum-
lI1g or hampered by add itiona l substances present in the samples to 
be tested, w hich show either similar bio logic or inhibitory activity. 
In contrast, immunologic assays using monoclonal anti- NAP-l / 
IL-8 antibodies appear feasibl e for quick and easy measurement of 
NAP-l / IL-8 in any biologic fluid . 
. In our laboratory we have now established a sandwich enzyme-
1ll1ked Immunosorbent assay (ELISA), wh ich is both specific and 
senSItive for the peptide. We have examined the time- and stimu-
lus-dependent production and secretion of interl eukin (IL)-8 pep-
tide by human fibroblasts and endothelial cells using IL-8 antibodies 
(11) in both immunocytochemistry and ELISA. A distinct pattern of 
reactivity was fou nd for each of these cell types, proving them to be 
most efficient producers of the pro-inflammatory peptide. 
MATERIALS AND METHODS 
Primary Cell Culture of Human Dermal Fibroblasts and Umbilical 
Vein Endothelial Cells Human fibroblasts were obtained from human 
dermis after heat separation of the epidermis [6]. Endothelial cells were 
harvested from human umbilica l veins followin g collagenase digestion [8). 
Both cell types wer.e cu l ture~ as described before [6,8) and regularly passaged 
after tryptiC dIgestion (0.05 Vo w /v trypSll1, 0.02% w /v ethelenediaminete-
traacetic acid [E~TA)). For stimulation experiments, cells were grown on 
pl ~s tIC coversiIps I1l 24-well culture plates. Incubation with respective stim-
ulI (human recombll1ant mterleukin-la [llrIL-lal 100 U/ml, hr tumor 
necrosIs factor [TNF)-a 100 ng/ml, hr interferon [IFN]-yl00 U/ ml , lipo-
polysaccha:lde (LPS) 1 j.lg/ ml, phorbol myristate acetate (PMA) 50 ng/ml) 
as well as time ll1tervals (1 - 18 h) are indicated. hrIL-1a was obtained from 
H?ffmann-La Roche, Basel, Switzerland, hrTNFa from Knoll/BASF, Lud-
wlgshafen , Germany, HrIFNy from Genentech Inc., San Francisco, CA, 
L.PS (S. Mi~1l1esota) from Calbiochem, Marburg, Germany, and PMA from 
SIgma, HeIdelberg, Germany. Culture supernatants as well as coverslips 
~ere recovered for sandwich ELISA and immunocytochemistry, respec-
tively. 
Monoclonal NAP-l/IL-8 Antibodies Monoclonal antibodies (MoAbs) 
were produced and characterized as described earlier [II). Mice had been 
immunized with natural NAP-l / IL-8 purified from supernatants of stimu-
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lated human peripheral blood monocytes. MoAbs were purified from spent 
cul ture medium of respective hybridoma clones by ammoruum sulfate pre-
cipitation and subsequent chromatography on fast protein liquid chroma-
tography (FPLC) protein A columns (Pharmacia-LKB, Bromma, Sweden). 
Before being used in·the sandwich ELISA, aliquots of monoclonal antibodies 
were coupled to N-hydroxy-succinimidobiotin according to manufacturer's 
instructions (Sigma, Heidelberg, Germany). 
Immunocytochemical Detection of NAP-l/IL-8 in Cultured 
Human Fibroblasts and Endothelial Cells Cells grown and stimulated 
on coverslips were fixed in 4% paraformaldehyde (v/v) in water for 10 min 
at room temperature. After washing they were incubated with anti - NAP-
1/ IL-8 MoAb 52E8 contained in spent culture supernatant (RPMI 1640, 7% 
FCS). Appropriate dilutions had been tested in advance. Immunoreactivity 
was detected using the avidin-biotin-peroxidase technique (ABC-kit, Vector 
Laboratories, Burlingame, CAl and diaminobenzidine as substrate. Two 
hundred cells were microscopically counted and the percentage of intracel-
lularly stained ce lls was determined. 
NAP-l/IL-8 Sandwich ELISA Polystyrene plates were coated over-
night at 4·C with purified antibody (10 J.lg/ml) in sodium carbonate buffer, 
pH 8.9, and blocked thereafter with 1% BSA (w/v) in phosphate-buffered 
saline (PBS) for 1 h at room temperature. Samples were incubated in dupli-
cate at 100-J.lI volumes for 1 h at room temperature. After washing, biotiny-
lated MoAbs were added at appropriate dilutions tested in advance. The 
enzymatic color reaction was performed using the avidin-biotin-peroxidase 
method (ABC-kit, Vector Laboratories) and o-phenylendiamin as substrate. 
Optical density was measured at 492 nm in a Behring ELISA processor II. 
Peptides from the p-Thromboglobulin Supergene Family Tested in 
the Sandwich ELISA Peptides from the p-thromboglobulin (P-TG) su-
pergene fam ily were either commercially available (platelet factor 4 [PF 4J; 
UCB, Belgium) or kindly provided by Dr. E. Brandt, Forschungsinstitut 
Borstel, Germany (P-TG, NAP-2). 
N AP-1 /IL-8 (72-residue form) was purified in our laboratory fro m super-
natants of stimulated human monocytes as described earlier [5J. After HPLC 
analysjs, the peptide was quantified by measuring optical density at 215 nm. 
In addition, the number of 50% effective doses (EDso) of chemotaxis was 
evaluated [5J. One EDso in this test system represents an IL-8 concentration 
of about 1 ng/ ml. 
RESULTS 
Immunocytochemical Detection ofNAP-l/IL-8 in Cultured 
Human Fibroblasts and Endothelial Cells Incubation of both 
endothelial cells and fibroblasts with IL-la and TNF-a resulted in 
the appearance of intracellular IL-8 immunoreactivity as early as 
after 1 h (Figs la,b, 2). Thirty to fifty percent of cells were stained in 
a coarse focal pattern located near the nucleus. The percentage of 
positive cells rose to 60 - 70% after 4 h and to more than 90% after 
8 h (Fig 2b,d ). IL-8 immunoreactivity remained at this level upon 
furth er incubation for up to 18 h. 
Similar resul ts of a distinct increase of intracell ular IL-8 immuno-
reactivity were seen in endothelial cells upon incubation with PMA 
or LPS, whereas IFN-y did not induce detectable effects (Fig Ib) . In 
contrast, fibrobl asts did not respond to any of these three stimuli 
(PMA, LPS, IFN-y) at any time interval tested (Fig la). 
NAP-l/IL-8 Sandwich ELISA Different combinations of 
monoclonal NAP-l / IL-8 antibodies (S C4, 14E4, 46E5, 52ES) were 
tested for sensitivity and specificity. As shown in Fig 3, the combi-
nation of MoAb 52ES as coating and SC4 as detecting antibody is 
able to detect NAP-1/IL-S down to 0 .2 ng/ml. With CTAP III , 
NAP-2, fJ-TG, and PF 4, in any of the possible antibody combina-
tions, only minimal extinction could be found even at very high 
concentrations (100 ng/ml). This finding excludes the possibility 
that these peptides act as potential cross-reactants causing false-posi-
tive results. For subsequent experiments, the combination of MoAb 
52ES as coating and SC4 as detecting antibody was used. 
Testing supernatants of stimulated human fibroblasts and endo-
thelial cells revealed a dose- and time-dependent increase of NAP-
1 / IL-S concentrations that was parallel to the increasing intracellu-
lar staining of both cell types (Fig 4a,b). After stimulation with 
IL-la (100 ng/ml), 10 -20 ng/l11l NAP-l/IL-S can be detected in 
the culture supernatant of both cell types during the first 2 h of 
incubation. With prolonged incubation time, IL-S rose up to 100 
ng/ml after IS h. With TNF-a, similar results were obtained in 
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Figure 1. Percentage of immunocytochemically stained cells in (aJ dermal 
fibroblasts, (bJ endothelial cells demonstrating time- and stimulus-depen_ 
dent intrace llular production ofNAP-l/IL-8 (hrIL-la 100 U/m!, hrTNF-
a 100 ng/ ml, hrIFN-y 100 U/ ml, LPS 1 J.lg/ml, PMA 50 ng/ml). After 
staining with monoclonal anti - N AP-l / IL-8 antibody 46E5 , 200 cells were 
counted and the percentage of intracel lularly stained cells was determined. 
Error bars, standard deviation. 
both cell types. In contrast to PMA, LPS, and, to some extent, 
IFN-y, which are able to induce IL-8 secretion in endothelial cells 
(Fig 4b), no response to these stimuli was seen in fibroblasts (Fig 4a). 
DISCUSSION 
A number of different cell types have in the past been shown to 
produce NAP-l/IL-S either constitutively or after stimulation with 
various stimuli [1,2]. Apart from monocytes [1,2,5], various sessile ' 
cutaneous cell populations like endothelial cells [8] , fibroblasts 
[6,7], and keratinocytes [7 ,12] "1" were shown to produce the peptide 
or variants thereof. Furthermore, alveolar macrophages [14], me-
sothelial cells [15], chondrocytes [1 6], and synovial macrophages 
[17] are able to produce IL-S. 
Recently, we have extensively characterized monoclonal anti-
bodies that have been raised against natural NAP-l / IL-S purified 
from supernatants of human peripheral monocytes [11 ,13]. The 
four MoAbs used in this study (SC4, 14E4, 46E5 , 52E8) do react 
with fibroblast-derived IL-S (FINAP) [6,1 3], a 77-amino acid ex-
tended version of the 72-al11ino acid genuine peptide, and with 
endothelial-cell-derived NAP (ENAP) [S,13], a processed 69-
amino acid form [8]. Consequently, the ELISA immunoreactivity in 
supernatants as well as the intracellular staining of stimulated 
human fibroblasts and endoth elial cells as demonstrated in this 
study can be attributed to NAP-l / IL-S or variants thereof. 
In earl ier studies on cultu red human fibroblasts [I S] and periph-
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Figure 2. Immunocytochemical staining with monoclonal anti-NAPoli 
lL-8 antibody 46E5 demonstrating intracellular focal stauung of fibroblasts 
[(b) bars, 50 ,urn] and endothelial cells (d) bars 50 ,urn) after stllnulatJOn with 
IL-la (100 U/ml) for 8 h. a) fibroblasts prior to stimulation; c) endothelial 
cells prior to stimulation (bars, 50,um). 
era! monocytes [19] using mRNA ill situ hybridization as wel l as 
IL-8 immunoassays, we have been able to demonstrate the sequence 
of events from transcription ofIL-8 message, expression of intracel-
lular IL-8, to release of IL-8. 
Using Northern blot in combination with RIA techniques, Kris-
tensen et af [20] recently were able to demonstrate IL-8 messag~ and 
peptide in endothelial cells, fibroblasts, and kerat1l10cytes stunu-
lated with IL-1a. IL-8 was, however, not localIzed wlth1l1 the cells. 
In the present study, our previous observations have now been ex-
tended using additional stimuli as well as different cell types that 
demonstrate ready and distinct production of IL-8. Furthermore, 
the consecutive steps ofIL-8 expression were pursued by comparing 
intracellular IL-8 expression and IL-8 secretion. Accordingly, upon 
stimulation IL-8 is not only readily expressed, but also stored intra-
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Figure 3. Sandwich-ELISA results with MoAb 52E8 as coating and MoAb 
8C4 as detecting antibody. NAP-l/IL-8 and related platelet-derived pep-
tides were tested in the concentrations indicated. 
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Figure 4. ELISA detection ofNAP-l / IL-8 demonstrating time- and stim-
ulus-dependent secretion (hriL-la 100 U/ml. hrTNF-a 100 ng/ml. 
hrlFN-J' 100 U/ml, LPS 1 Jig/ ml, PMA 50 ng/ml) . aJ dermal fibroblasts ; b), 
endothelIal cells) . Error bars, standard deviation. 
cellularly as well as secreted. The number of pro-inflammatory 
stimuli capable of inducing IL-8 in both endothelial cells (LPS, 
PM~, ILl-a, TNF-a) and fibroblasts (TNF-a , ILl-a) emphasizes 
the Important role of these stimuli as wel l as of IL-S under inflam-
matory conditions. 
From the clinical point of view, testing biologic fluids for NAP-
1/IL-8 conte~t would be of great interest. Any biologic assay may, . 
however, be l11.fluenced by the presence of additional factors that 
could either stimulate or inhibit functional activities of the respon-
der cells. TI11S could cause major problems when analyzing complex 
bIOlogiC fllllds for the pres~nce of biologically important factors. 
In recent studIes, a famIly of structurally rela ted peptides has 
emerged called the fJ-thromboglobulin supergene fami ly [21]. 
Among them are platelet-derived peptides like platelet factor 4 [22], 
fJ-thromboglobulin [23]' its precursor molecule CTAP III [24], or 
processed forms like NAP-2 [25] . 
. An ELISA as described here for detecting the IL-8 molecule helps 
CIrcumvent these problems. Our assay proved to be both sensitive 
and specific for the measurement of the peptide content in biologic 
fluids. Indeed, in our ELISA format no related peptide could be 
detected (data for PF 4 not shown) and therefore these can be ex-
cluded as a m~or source of immunoreactivity. 
A further aspect of immunoreactivity noted under these condi-
tions relates to precursor molecules of IL-8 or processed forms. 
Preliminary data from our laboratory reveal that several peptides 
with hi gher molecular weight seem to exist that lack biologic activ-
ity although they can be detected by the antibodies raised against 
IL-S. At present this immunoreactive material has not been exam-
ined biochemically. 
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In our assay the standard curve was established by the use of 
genuine NAP-l/IL-8 purified from human monocyte supen~atants 
[5]. Quantification was performed by measunng optical denSity and 
determining the number of EDso, present in the preparatIOn. The 
equivalent of one EDso was established at 1 ng/ml [5]. 
These data may serve as a baseline for further standard ization of 
this molecule in biologic fluids. Unfortunately, up to now use of 
different immunoassays has hampered careful quantification of 
NAP-l/IL-8, as pointed out previously [26]. 
It wi ll be interesting to study NAP-l/IL-8 contents in different 
pathologic conditions as well as in relation to disease activity to find 
out whether the peptide can be detected within the circulation or is 
locall y restricted to the site of inflammation. 
We gra tefu lly acknowledge tile excellwi techllical assistance oj Miss Alike Rose. 
This work was supported ill pari by a Deutsche ForsciJlltlgsgemeillschajt grallt 
(sti 95/2-1). 
REFERENCES 
1. Leonard EJ, Yoshimura T: Neutrophil attractant/activating protein-1 {NAP-l 
(Interleukin 8)). Alii] Resp Cell Mol Bioi 2:479-486, 1990 
2. Baggiolini M, Walz A, Kunkel S: Neutrophil activating peptide I/interleukin-8, 
a novel cytokine that activates neutrophils.] Clin [IIIIest 84:1045 - 1 049, 1989 
3. Schroder ]-M, Christophers E: The biology of NAP-l/IL-8, a neutrophil-acti-
vating cytokine . In: Coffey RG (cd.). CrQ/wlocyte resPOIISes to cytokilles. Marcel 
Dekker, New York, Basel, Hong Kong, 1992, pp 387-416 
4. Schroder ] -M, Christophers E: Identification of C5ad_. and an anionic neutro-
phil-activating peptide (ANAP) in psoriatic scales.] [1111<51 Derlllatol 87:53 - 58, 
1986 
5. Schroder ]-M, Mrowietz U, Morita E, Christophers E: Purification and partial 
biochemical characterization of a human monocyte-derived neutrophil-acti-
vating peptide that lacks interleukin 1 activity.] [111111111101139:3474-3483, 
1987 
6. Schroder J-M, Sticherling M, Henneike HH, Preissner WC, Christophers E: 
IL-la or TNF-a stimulate release of three IL-8 related neutrophil chemotactic 
protei ns in human dermal fibroblasts.] [111"'"110/144:2223-2232,1990 
7. Larsen CG, Anderson AO, Oppenheim JJ , Matsushima K: Production of inter-
leukin-8 by human dermal fibroblasts and keratinocytes in response to interleu-
kin-lor tumor necrosis factor. [n",nlllology 68:31 - 36, 1989 
8. Schroder J-M, Christophers E: Secretion of novel and homologous neutrophil-
activating peptides by LPS-stimulated human endothelial cells.] [lIImllllol 
142:244 -251,1989 
9. Gimbrone MA, Obins MS, Broc AF, Luis EA, Hass PE, Hebert CA, Yip YK, 
Leung OW, Lowe DG, Kohr WJ, Dabronne WC, Bechtal KB, Baker JB: 
Endothelial interleukin-8: a novel inhibitor of leucocyte endothelial interac-
tion. SciC'lCC 246: 1601 - 1603, 1989 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
10. Larsen CG, Anderson AO, Appella E, OppenheimJJ, Matsushima K: The neu-
trophil-activating protein (NAP-I) is also chemotactic for T -lymphocytes. 
Scicllce 243:1464- 1466,1989 
11. Sticherling M, Schroder J-M, Christophers E: Production and characterization of 
monoclonal antibodies against the novel neutrophil activating peptide NAP / 
IL-8.] 111111111110/143:1628-1634,1989 
12. Schroder J-M, Sticherling M, Smid P, C hristophers E: Interleukin 8 and other 
stmcturally related cytokines. In: Luger T , Schwarz T (cds .). Epiderlllal CYlo-
killes. CRC Press , Boca Raton (in press) 
13. Sticherling M, Schroder J-M, Christophers E: Detection of NAP-1/IL-8 and 
related peptides from different sources by monoclonal antibodies. In: Oppen-
heim JJ , Powanda MC, Kluger MJ, Dinarello CA (cds.). MolcCIIlar alld celllliar 
biology of cytokilles. Alan R. Liss, New York, 1990, PP 339 - 344 
14. Carre PC, Mortenson RL, King Jr. TE, Noble PW , Sable CL, Riches DWH: 
Increased expression of the interleukin-8 gene by alveolar macrophages in 
idiopathic pulmonary fibrosis. ] Clill ill vest 88:1802-1810, 199 1 
15. Goodman RD, W ood RG , Martin TR, Hanson-Painton 0, Kinasewitz GT: Cy-
tokille-stimulated human mesothelial ce lls produce chemotactic activity for 
neutrophils including NAP- I / IL-8.] 111l1l1l1l101148:457 - 465 , 1992 
16. Lotz M, Terkeltaub R, Villiger PM: Cartilage and joint inflammation: regulation 
oflL-8 expression by human articular chondrocytes.] ['11 III 11,101 148:466-473, 
1992 
17. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Strieter 
RM: Synovial tissue macrophage as a source of the chemotactic cytokine IL-S. 
] ltlllllllllol 147:2187-2195, 1991 
18. Mielke V, Bauman JGJ, Sticherling M, Ibs T,. Zomershoe AG, Seligmann K, 
Henlleicke HH, Schroder J-M, Sterry W, ChrlStophers E: Detection of neutro_ 
phil-activating peptide NAP-l/IL-8 and NAP- I/IL-8 mRNA in human re-
combinant IL-la- and human recombinant tumor necrosis factor a-stimu_ 
lated human dermal fibroblasts. ] [IIII'lImol 144:153-161,1990 
19. Mrowietz U, Sticherling M, Mielke V, Schroder J-M, C hristophers E: Neutro_ 
phil-activating peptide l / interleukin 8 mRNA expression and protein secre-
tion by human monocytes: effect of cyclosporin A. Cytokillc 3:322-326,1991 
29. Kristensen MS, Palud.n K, Larsen CG, Zachariae COC, Deleuran B, Jensen 
PKA, Jorgensen P, Thestrup-Pedersen K: Quantitative determination of IL-
Ia-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibro-
blasts, endothelial cells, and monocytes.] ltlllest Derlllatol 3:506 - 510, 1991 
21. Schroder J-M: The neutrophil-activating peptide (N AP-l/Interleukin 8), a novel 
cytokinc of the p-thromboglobulin supergene family. In: Sorg C (cd .). Natural 
resistallce to i,ifectioll. Localltlllllllllity 6. G. Fischer, Stuttgart, New York, 1990, 
pp 50- 59 
22. Deuel TF, Keirn PS, Fanner M, Heinrikson RL: Amino acid sequence of human 
platelet factor 4. Proc Na t! Acad Sci USA 80:765-769, 1983 
23. Begg GS, Pepper OS, Chesterman CN, Morgan FJ: Complete covalent strUCture 
of human p-thrornboglobulin . Biochelllistry 17: 1739-1744, 1978 
24. Castor CW, Miller ]W, Walz DA: Structural and biochemical characteristics of 
connective tissue act ivating peptide (CTAP-III), a major human platelet-
derived growth factor . Proc Nat! Acad Sci USA 80:765- 769, 1983 
25. Walz A, Baggiolini M: Generation of the neutrophil-activating peptide NAP-l 
from platelet basic protein or connective tissue activating peptide 11\ through 
monocyte proteases.] Ex!, Med 171:449-454,1990 
26. Westwick J, Li SW, Camp RD: Novel neutrophil-stimulating peptides. [Illmll-
lIology Today 10:146- 147,1989 
----
